Review article · 2000 · Open access

Novel antipsychotics: issues and controversies. Typicality of atypical antipsychotics.

Émmanuel Stip

PubMed, 25(2), 137–153 · Published 1 March 2000

Open full textView at the publisherCite this paper

In brief

“Novel antipsychotics: issues and controversies. Typicality of atypical antipsychotics.” is a 2000 review article by Émmanuel Stip, published in PubMed. OpenAlex counts 82 citations as of 20 November 2026. It is open access: the full text is free to read at PubMed Central.

Citations
82
Most cited in
2013 (3)
Field-weighted impact
0.97
References
133
Authors
1

Abstract

The typicality of atypical antipsychotic drugs remains debatable. Preclinical studies and findings from randomized, controlled and open trials of clozapine, olanzapine, risperidone, quetiapine, sertindole, ziprasidone and a substituted benzamide were examined. A MEDLINE search was conducted using key words, including "extrapyramidal side effects," "cognition," "schizophrenia" and the generic drug names. Over 140 articles from peer-reviewed journals were reviewed, some of which were based on a meta-analysis. New-generation neuroleptic agents were found to have greater efficacy on the negative symptoms of schizophrenia and to cause fewer unwanted extrapyramidal side effects (EPS) than the traditional antipsychotic drugs. On one hand, atypical neuroleptic agents could be strictly defined as any neuroleptic agent with antipsychotic effects at a dosage that does not cause extrapyramidal side effects. Thus, clozapine is regarded as the "standard" atypical antipsychotic drug. On the other hand, typicality is about dimension rather than category, and we suggest the use of the term "spectrum of atypicality." For example, an emphasis is placed on quetiapine to illustrate where a new compound fits in this spectrum. Although dose-related, atypicality may be more a question of prescription attitude than of a specific characteristic of a compound. The degree to which a new compound is clinically superior to another atypical antipsychotic drug, in terms of improving positive, negative or affective symptoms, cognitive function and long-term outcome, will require further a priori hypotheses based on conceptual frameworks that are clinically meaningful. In addition, the results from industry-sponsored trials should be more comparable to those obtained from investigator-leading trials. Finally, the patient characteristics that define a patient's response to a specific antipsychotic drug are unknown.

Cite this paper

Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.

APA 7

Stip, É. (2000). Novel antipsychotics: issues and controversies. Typicality of atypical antipsychotics. PubMed, 25(2), 137–153. https://pubmed.ncbi.nlm.nih.gov/10740987

MLA 9

Stip, Émmanuel. “Novel antipsychotics: issues and controversies. Typicality of atypical antipsychotics.” PubMed, vol. 25, no. 2, 2000, pp. 137–153. https://pubmed.ncbi.nlm.nih.gov/10740987.

Chicago

Stip, Émmanuel. 2000. “Novel antipsychotics: issues and controversies. Typicality of atypical antipsychotics.” PubMed 25 (2): 137–153. https://pubmed.ncbi.nlm.nih.gov/10740987.

Harvard

Stip, É. (2000) ‘Novel antipsychotics: issues and controversies. Typicality of atypical antipsychotics.’, PubMed, 25(2), pp. 137–153. Available at: https://pubmed.ncbi.nlm.nih.gov/10740987.

IEEE

É. Stip, “Novel antipsychotics: issues and controversies. Typicality of atypical antipsychotics.,” PubMed, vol. 25, no. 2, pp. 137–153, 2000.

BibTeX

@article{stip2000novel,
  title     = {{Novel antipsychotics: issues and controversies. Typicality of atypical antipsychotics.}},
  author    = {Stip, Émmanuel},
  journal   = {PubMed},
  year      = {2000},
  volume    = {25},
  number    = {2},
  pages     = {137--153},
  url       = {https://pubmed.ncbi.nlm.nih.gov/10740987}
}

Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)

Citations by year

YearCitationsShare of the best year
201211
201333
201433
201522
201711
201911
202011
202233

Its field-weighted citation impact is 0.97: it has been cited 0.97 times as often as the average work of the same field, type and year (1.00 is the world average).

Topic and keywords

Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment

  • atypical antipsychotics
  • typicality
  • schizophrenia
  • extrapyramidal symptoms
  • negative symptoms
  • quetiapine
  • clozapine
  • olanzapine

Work with this paper

Most-cited papers in Medicine

All highly cited Medicine papers

Questions about this paper

How do I cite this paper in APA style?

Stip, É. (2000). Novel antipsychotics: issues and controversies. Typicality of atypical antipsychotics. PubMed, 25(2), 137–153. https://pubmed.ncbi.nlm.nih.gov/10740987

How many times has this paper been cited?

82 times, according to OpenAlex on 20 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.

Is this paper free to read?

Yes. It is open access at PubMed Central: sign in and open the full text from this page.

Who wrote this paper?

Émmanuel Stip.

Bibliographic data from OpenAlex (CC0), last checked 20 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.